Navigation Links
Studies Show Pharma has a Strong Opportunity to Market to New Decision Makers via Digital Channels
Date:2/7/2013

NEW YORK, Feb. 7, 2013 /PRNewswire/ -- Many leading pharmaceutical companies are shifting their sales and marketing strategies to expand their customer focus beyond the physician and the patient to include payers, nurses, and pharmacists. These emerging players have a growing influence on the medications and treatments prescribed to patients, an influence that is likely to intensify as strategies to improve outcomes and reduce costs are implemented through Accountable Care Organizations, formularies and other changing dynamics of the healthcare marketplace.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36806LOGO )

Recent studies from healthcare market research and advisory firm Manhattan Research reveal a compelling opportunity for pharmaceutical companies to leverage digital media and online channels to reach and provide services to these emerging customers. Formulary decision makers, nurses and pharmacists are digitally savvy, are already engaging with pharmaceutical companies and indicate strong interest in support and services from pharmaceutical companies to manage their changing mandate:

  • Over 4 in 5 hospital-based formulary decision makers are interested in any form of ongoing support and resources from pharma, including help with such items as developing provider education materials, economic models, and patient education materials.
  • Over 3 in 4 retail, hospital and specialty pharmacists have used or are interested in using online promotional activities from pharma. These online promotional programs include webinars, self-guided virtual details, and live 1:1 sessions with reps.
  • 3 in 5 registered nurses expressed interest in accessing information on patient assistance programs, and links to disease sites for professionals on pharma and device manufacturer websites.

"Pharma is reconsidering who their customer is – and not a day too soon," said Monique Levy , Vice President of Research at Manhattan Research. "The good news is that nurses, formulary decision makers and pharmacists are highly accessible online and recognize that pharma can add value and help them succeed in this new outcome-based world."

Upcoming Conference! iPharma 2013 - Digging for Data — Breakdown of Emerging Audience Members for Pharma Digital Promotion, Tuesday, February 12 at 2:10 pm ET

Vice President of Research, Monique Levy is presenting "Digging for Data — Breakdown of Emerging Audience Members for Pharma Digital Promotion" at the 2013 iPharma conference for those interested in learning more about Taking the Pulse® Pharmacists, Taking the Pulse® Formulary Decision Makers and Taking the Pulse® Nurses, as well as highlights from the new data. Register today!

About Taking the Pulse® Formulary Decision Makers 2012
Taking the Pulse® Formulary Decision Makers from Manhattan Research is designed to address the unique challenges faced by marketers targeting formulary decision makers (P&T committee members) in payer organizations, PBMs, and large hospitals. The study explores the formulary and pre-authorization decision making process, as well as how formulary decision makers use the Internet, key digital information sources and other pharma-provided services and tools. The study surveyed 205 Managed Care Organizations (MCOs), Pharmacy Benefit Managers (PBMs), and Hospital Pharmacy & Therapeutic (P&T) committee members in the United States in October of 2012. For more information, please visit www.manhattanresearch.com/ttpfdm.

About Taking the Pulse® Pharmacists 2012
Taking the Pulse® Pharmacists from Manhattan Research is focused on how U.S. pharmacists use various channels and sources, including digital content and mobile devices, for professional purposes, pharma interaction, and patient care. The study surveyed 752 U.S. pharmacists online in September and October of 2012. For more information, please visit www.manhattanresearch.com/ttppharmacists.

About Taking the Pulse® Nurses 2012
Taking the Pulse® Nurses is Manhattan Research's annual market research study and syndicated advisory service focused on how U.S. nurses, advanced practice registered nurses (APRNs) and physician assistants (PAs) use the Internet, digital media, mobile devices and other technologies for professional purposes, pharma communication and patient interaction. The study was fielded in Q2 2012 among 1,019 U.S. practicing nurses and physician assistants. For more information, please visit www.manhattanresearch.com/ttpnurses.

About Manhattan Research
Manhattan Research, a Decision Resources Group company, conducts annual research studies covering digital health trends among healthcare professionals and consumers in the Americas, Europe, and Asia-Pacific. Broad research can be segmented by target specialist and therapeutic audiences. For more information please contact sales@manhattanresearch.com, call 1.888.680.0800, ext 2, or visit www.manhattanresearch.com.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders

For more information, contact:

Manhattan Research
Stephanie Cooper
212-255-1368 
scooper@manhattanresearch.com


'/>"/>
SOURCE Manhattan Research
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GLP Preclinical Studies Demonstrate nContact Ablation Lesions Are Complete and Transmural
2. Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
3. The Lancet Publication Of LAPLACE-TIMI 57 And MENDEL Studies Showed AMG 145 Significantly Reduced LDL Cholesterol
4. Novel Apolipoprotein A-I Therapy, CSL112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show
5. Amgen To Present Data From Four Phase 2 Studies At Upcoming American Heart Association Scientific Sessions 2012
6. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
7. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
8. Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
9. PartTecs Newly Licensed Neutron Detector Will Advance Human Disease Studies
10. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
11. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):